A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis

NCT07020715 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
14
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Antwerp

Collaborators